ReviewCambridge prisms. Precision medicine2025

Biomarker understanding first lessons from drug development for IgA-driven autoimmune and fibrotic diseases.

Myrthe Alexandra Maria van Delft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.